Brugada syndrome clinical update
| Autor: | Sei Iwai, Ethan Gregory Hoch, Risheek Kaul, Daniel Frenkel, Jason T. Jacobson, Wilbert S. Aronow, Rhadames Rojas |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
030204 cardiovascular system & hematology Ventricular tachycardia Sudden cardiac death Diagnosis Differential Electrocardiography 03 medical and health sciences 0302 clinical medicine Asian People Risk Factors Internal medicine medicine Humans ST segment cardiovascular diseases 030212 general & internal medicine Brugada Syndrome Brugada syndrome Fibrillation medicine.diagnostic_test business.industry fungi General Medicine medicine.disease Defibrillators Implantable Blockade Death Sudden Cardiac Catheter Ablation Etiology Cardiology medicine.symptom business Anti-Arrhythmia Agents |
| Zdroj: | Hospital Practice. 49:255-261 |
| ISSN: | 2377-1003 2154-8331 |
| Popis: | Brugada syndrome (BrS) was initially described in southeast Asians with a structurally normal heart presenting with polymorphic ventricular tachycardia and fibrillation. This condition is marked by J-point elevation ≥ 2 mm with coved-type ST segment elevation followed by negative T wave inversions in at least one precordial lead (V1 or V2) when other etiologies have been excluded. These changes on electrocardiogram (EKG) can either be spontaneous or manifest after sodium channel blockade. The worldwide prevalence of BrS is about 0.4%; however, it is higher in the Asian population at 0.9%. This article will review the current hypotheses regarding the pathophysiology, spectrum of clinical presentation, strategies for prevention of sudden cardiac death and the treatment for recurrent arrhythmias in BrS. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|